MAM
BDSI

Martingale Asset Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Martingale Asset Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-90,397
Closed -$281K – 900
2021
Q4 		$281K Buy
90,397
+8,488
+10% +$28.6K ﹤0.01% 750
2021
Q3 		$296K Buy
81,909
+50,300
+159% +$190K ﹤0.01% 753
2021
Q2 		$114K Sell
31,609
-11,511
-27% -$40.6K ﹤0.01% 818
2021
Q1 		$169K Sell
43,120
-297
-0.7% -$1.23K ﹤0.01% 827
2020
Q4 		$183K Sell
43,417
-204,700
-83% -$789K ﹤0.01% 848
2020
Q3 		$927K Sell
248,117
-226,577
-48% -$964K 0.01% 654
2020
Q2 		$2.07M Hold
474,694
– – 0.02% 521
2020
Q1 		$1.8M Sell
474,694
-5
-0% -$25 0.02% 511
2019
Q4 		$3M Buy
474,699
+223,066
+89% +$1.31M 0.03% 498
2019
Q3 		$1.06M Buy
+251,633
New +$1.07M 0.01% 753

Other funds holding BDSI

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
FCMT
Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Martingale Asset Management's BDSI Position: Q1 2022 in Review

Martingale Asset Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 90,397 shares — an estimated $281K sold.

Martingale Asset Management first reported a position in BDSI in Q3 2019 and held it in 10 quarters. The position peaked at $3M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • Martingale Asset Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • Martingale Asset Management sold 90,397 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $281K.
  • Martingale Asset Management first reported a position in BioDelivery Sciences International, Inc. in Q3 2019 and held it in 10 quarters.
  • Martingale Asset Management's BioDelivery Sciences International, Inc. position peaked at $3M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Martingale Asset Management's 13F filing for Q1 2022, filed 12 May 2022.